Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
8.66
-0.72 (-7.68%)
At close: Dec 5, 2025, 4:00 PM EST
8.83
+0.17 (1.96%)
After-hours: Dec 5, 2025, 7:42 PM EST
Sutro Biopharma Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Sutro Biopharma stock have an average target of 19.67, with a low estimate of 8.00 and a high estimate of 30. The average target predicts an increase of 127.14% from the current stock price of 8.66.
Analyst Consensus: Hold
* Price targets were last updated on Aug 12, 2025.
Analyst Ratings
The average analyst rating for Sutro Biopharma stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 5 | 5 | 5 | 5 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $40 → $30 | Hold | Maintains | $40 → $30 | +246.42% | Aug 12, 2025 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $20 | Hold → Buy | Upgrades | $20 | +130.95% | Jun 16, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $10 → $8 | Sell | Maintains | $10 → $8 | -7.62% | May 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +130.95% | Apr 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $120 → $20 | Strong Buy → Hold | Downgrades | $120 → $20 | +130.95% | Mar 17, 2025 |
Financial Forecast
Revenue This Year
100.89M
from 62.04M
Increased by 62.61%
Revenue Next Year
46.45M
from 100.89M
Decreased by -53.96%
EPS This Year
-2.15
from -29.61
EPS Next Year
-1.32
from -2.15
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 115.5M | 98.6M | ||||
| Avg | 100.9M | 46.5M | ||||
| Low | 89.0M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 86.2% | -2.3% | ||||
| Avg | 62.6% | -54.0% | ||||
| Low | 43.5% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.97 | -0.63 | ||||
| Avg | -2.15 | -1.32 | ||||
| Low | -2.16 | -1.91 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.